These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25721705)

  • 1. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
    Fava GA; Gatti A; Belaise C; Guidi J; Offidani E
    Psychother Psychosom; 2015; 84(2):72-81. PubMed ID: 25721705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Fava GA; Benasi G; Lucente M; Offidani E; Cosci F; Guidi J
    Psychother Psychosom; 2018; 87(4):195-203. PubMed ID: 30016772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
    Renoir T
    Front Pharmacol; 2013; 4():45. PubMed ID: 23596418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRI withdrawal syndrome in children and adolescents: a narrative literature review.
    Khan YS; Khoodoruth MAS; Albobali Y; Haddad PM
    Expert Opin Drug Saf; 2023; 22(5):381-390. PubMed ID: 37339264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor 'discontinuation syndrome' or withdrawal.
    Massabki I; Abi-Jaoude E
    Br J Psychiatry; 2021 Mar; 218(3):168-171. PubMed ID: 31902371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.
    Cosci F; Chouinard G
    Psychother Psychosom; 2020; 89(5):283-306. PubMed ID: 32259826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Handley AP; Williams M
    J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous anti-obsessive agents: a review.
    Ravindran LN; Jung SM; Ravindran AV
    J Psychopharmacol; 2010 Mar; 24(3):287-96. PubMed ID: 18801828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature ejaculation associated with citalopram withdrawal.
    Adson DE; Kotlyar M
    Ann Pharmacother; 2003 Dec; 37(12):1804-6. PubMed ID: 14632589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the management of antidepressant discontinuation symptoms.
    Wilson E; Lader M
    Ther Adv Psychopharmacol; 2015 Dec; 5(6):357-68. PubMed ID: 26834969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSRI-Induced Indifference.
    Sansone RA; Sansone LA
    Psychiatry (Edgmont); 2010 Oct; 7(10):14-8. PubMed ID: 21103140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review.
    Sørensen A; Jørgensen KJ; Munkholm K
    J Affect Disord; 2022 Nov; 316():177-186. PubMed ID: 35964766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin Toxicity Versus Withdrawal: Clonidine One Size Fits All?
    Burdine J; Luedtke S
    J Pediatr Pharmacol Ther; 2021; 26(5):502-517. PubMed ID: 34239404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ssri-related toxic serotonin syndrome: improvement by discontinuation of treatment and propranolol.
    Dursun SM; Burke JG; Nielsen F; Mlynik-Szmid A; Reveley MA
    Eur Psychiatry; 1997; 12(6):321-3. PubMed ID: 19698545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication.
    Groot PC; van Os J
    Ther Adv Psychopharmacol; 2020; 10():2045125320932452. PubMed ID: 32699604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of a Missed History: A Case of Antidepressant Discontinuation Syndrome.
    Hameed S; Kumar M; Puri P; Sapna F; Athwal PSS
    Cureus; 2020 Oct; 12(10):e10950. PubMed ID: 33209514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.
    Guy A; Brown M; Lewis S; Horowitz M
    Ther Adv Psychopharmacol; 2020; 10():2045125320967183. PubMed ID: 33224468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuing benzodiazepines: best practices.
    Guaiana G; Barbui C
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):214-6. PubMed ID: 26818890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.